Dapsone-Induced Hypersensitivity Pneumonitis Mimicking Pneumocystis carinii Pneumonia in a Patient with AIDS

American Journal of the Medical Sciences

Volumn 327, Issue 3, 2004, Pages 163-165

  Tobin D'Angelo, Melissa J ^a   Hoteit, Maarouf A ^a   Brown, Katia V ^a   Ray, Susan M ^a   King, Mark D ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alveolitis; Extrinsic allergen; Pneumocystis carinii; Pneumonia

Indexed keywords

ALLERGEN; CD4 ANTIGEN; CD8 ANTIGEN; CLINDAMYCIN; CORTICOSTEROID; COTRIMOXAZOLE; DAPSONE; LACTATE DEHYDROGENASE; METICILLIN; OXYGEN; PREDNISONE; PRIMAQUINE; SULFONAMIDE; VANCOMYCIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ALLERGIC PNEUMONITIS; ARTICLE; BLOOD CELL COUNT; BRONCHOSCOPY; CASE REPORT; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; HYPOXEMIA; LUNG LAVAGE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; OSTEOMYELITIS; PNEUMOCYSTIS PNEUMONIA; RASH; THORAX RADIOGRAPHY;

EID: 1542283706     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200403000-00010     Document Type: Article

References (16)

1. Schuyler M. The diagnosis of hypersensitivity pneumonitis. Chest 1997;111:534-6.
2. Valcke Y, Pauwels R, Van Der Straeten M. Bronchoalveolar lavage in acute hypersensitivity pneumonitits caused by sulfasalazine. Chest 1987;92:572-3.
3. Morris AM, Nishimura S, Huang L. Subacute hypersensitivity pneumonitis in an HIV infected patient receiving antiretroviral therapy. Thorax 2000;55:625-7.
4. Akoun GM, Mayyaud CM, Miller BJ, et al. Drug-related pneumonitis and drug-induced hypersensitivity pneumonitis. Lancet 1984;8390:1362-3.
5. Kohno S, Yanaguchi K, Yasuoka A, et al. Clinical evaluation of 12 cases of antimicrobial drug induced pneumonitis. Jpn J Med 1990;29:248-54.
6. Baillie J. Sulfasalazine and pulmonary infiltrates [letter]. Am J Gastroenterol 1984;79:77.
7. Benhrens GMN, Stoll M, Schmidt RE. Pulmonary hypersensitivity reaction induced by efavirenz. Lancet 2001;357:1503-4.
8. Janier M, Guillevin L, Badillet G. Pulmonary eosinophilia associated with dapsone. Lancet 1994;343:860-1.
9. Jaffuel D, Lebel B, Hillaire-Buys D, et al. Eosinophilic pneumonia induced by dapsone. BMJ 1998;317:181.
10. Reilly TP, Woster PM, Svensson CK. Methemoglobin formation by hydroxylamine metabolites of sufamethoxazole and dapsone: Implications for differences in adverse drug reactions. J Pharmacol Exp Ther 1999;288:951-9.
11. Holtzer CD, Flaherty JF, Coleman RL. Cross-reactivity in HIV-infected patients switched from trimethoprim-sulfamethoxazole to dapsone. Pharmacotherapy 1998;18:831-5.
12. Sviri S, Gafanovich I, Kramer MR, et al. Mesalamine-induced hypersensitivity pneumonitis. J Clin Gastroenterol 1997;24:34-6.
13. Pirmohamed M, Hussain CF, Breckenridge AM, et al. Direct and metabolism-dependent toxicity of sulphasalazine and its principal metabolites towards human erythrocytes and leucocytes. Br J Clin Pharmacol 1991;32:303-10.
14. Higgins T, Niklasson PM. Hypersensitivity pneumonitis induced by trimethoprim. BMJ 1990;300:1344.
15. D'Arcyl PF. Nitrofurantoin. Drug Intell Clin Pharm 1985;14:540-7.
16. Sattler F, Nichols L, Hirano L, et al. Nonspecific interstitial pneumonitis mimicking Pneumocystis carinii pneumonia. Am J Respir Crit Care Med 1997;156:912-7.